Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • bob-loblaw
    Member
    • Jun 2012
    • 59

    #1

    What proportion of 'bad' quality reads are expected using HiSeq 2000 for RNA-Seq

    I am just after processing 24 files, using trimmomatic to quality filter them. On average was 30% of the reads were bad quality (SD = 11).

    This seems somewhat high to me, I was just wondering if anyone else had experience with this and could tell me what would be expected? If I should be particularly concerned about this...

    Thanks.
  • westerman
    Rick Westerman
    • Jun 2008
    • 1104

    #2
    30% is indeed high. We -- I work at a sequencing center -- have seen such results but in these cases the problem is tracked down to sequencer problems, sample prep, or just an random problem. We almost always re-run the samples. Does fastQC show any particular place where the problem occurs?

    Comment

    • GenoMax
      Senior Member
      • Feb 2008
      • 7142

      #3
      Hopefully these samples did not come from an overloaded flowcell. (Assuming that you have taken into account the right Q-score parameters for trimmomatic)

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
        by SEQadmin2




        NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
        Yesterday, 06:46 AM
      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-28-2026, 09:57 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-28-2026, 09:51 AM
      0 responses
      15 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      71 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Working...